Obesity

Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

Bariatric surgery is associated with sustained, beneficial alterations in biomarkers of glycocalyx and endothelial function in patients with obesity, both with and without T2D. It is suggested that reduced body weight/fat mass and improved insulin sensitivity are of particular importance for these alterations.

Study context

Population
Adults undergoing bariatric surgery (RYGB preceded by a 2-week low-calorie diet), single center in Stockholm, Sweden
Participants
28 vs 33
Exposure
Before vs after RYGB, in patients with vs without T2D
  • T2Dn = 28
  • Without T2Dn = 33reference
Outcome
Plasma concentrations of glycocalyx biomarkers (hyaluronan and syndecan-1), E-Selectin, VWF and thrombomodulin
Follow-up
2 years after surgery
Methodological detailssingle-centre, 2-year follow-up
  • Single-centre
  • 2-year follow-up

Main finding

As reported in the abstract

E-Selectin decreased, geometric mean (CV%) (P < .001)

41 (40) to 24 (61) ng/mL

Syndecan-1 decreased (P < .001)

50 (73) to 38 (81) ng/mL

Von Willebrand factor (VWF) decreased (P < .001)

120 (52) to 103 (45)%

HA increased (P < .001)

25 (96) to 40 (78) ng/mL

Observational data: associations, not effects.

Further findings

OutcomeP value
Baseline biomarkers, T2D vs without T2DHigher E-Selectin with T2DP = 0.041
Biomarker change, T2D vs without T2DE-Selectin initially declined faster with T2DP < 0.003

Baseline biomarkers, T2D vs without T2D

Other biomarkers did not differ between groups

Biomarkers after low-calorie diet (LCD) · after 2-week LCD

E-Selectin, syndecan-1 and VWF were reduced

Biomarker change, T2D vs without T2D

Otherwise biomarker changes did not differ between groups

Predictors of biomarker improvement

Highest predictive value: decrease in body weight and fat mass and increase in insulin sensitivity (HOMA-IR)

Original publication

Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. Published 13 February 2025. doi:10.1210/clinem/dgaf092

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.